Reply I. Cord blood androgen measurement: the importance of assay validation
The results obtained by radioimmunoassay (RIA) and mass spectrometry (MS) methods are incomparable, because their detection principle and procedure are entirely different. Procedural losses of RIA are nonexistent as the samples are neither extracted, chromatographed nor transferred, while substantial losses are inevitable in routine extraction, purification and chromatography during MS, so it is meaningless to validate RIA results with MS method.
As a matter of fact, our results are close or comparable with many other studies employing the same method (van de Beek et al., 2004; Baik et al., 2006; Nagata et al., 2007; Garagorri et al., 2008; Hickey et al., 2009; Lagiou et al., 2011 Lagiou et al., , 2013 Lagiou et al., , 2014 AgursCollins et al., 2012; Zhou et al., 2013) , and consistent with the cord testosterone reference (Garagorri et al., 2008) . The values (median: 10.5 nmol/l) were even lower than the results (median: 12.43 nmol/l) reported by Hickey et al. (2009) , a co-author of the initial Letter to the Editor.
Furthermore, the testosterone reference study by Garagorri et al. (2008) confirmed that the cord testosterone level is highest after birth (mean: 239 ng/dl or 8.45 nmol/l), then decreases with age within 180 days after birth. It is well known that blood testosterone levels are low in women and children, but it does not necessarily mean the cord testosterone level is low too, so the adult male testosterone level extrapolated by Keelan et al. (260 nmol/l) is incorrect. We think commercial RIA kits can provide sufficient (albeit not optimal) information for the epidemiology study (as opposed to clinical decision). Since publication of our article we have validated our RIA method and compared with other RIA methods, and made sure that the method is valid and sound. Keelan et al. claim that dRIA methods were invalid in cord testosterone measurement and data were erroneous.
Extraction and cross-reactivity
Extraction is no longer a must procedure in commercially available RIAs (or direct RIA (dRIA)), as the detection principle is different from that of conventional ones. The enhanced efficiency, improved sensitivity, ease of performance and automation process have made dRIAs more available to clinicians and researchers, facilitating both clinical diagnosis and research. As for cord testosterone measurement in our experiment, the low cross-reactivity for potentially interfering steroids has been confirmed by the manufacturer (Union Medical & Pharmaceutical Technology, Tianjin, China). According to the technical manual, the 100% testosterone specificity combined with low blood levels of 5α-dihydrotestosterone (DHT) (35% cross-reactivity), 5β-DHT (0.8% cross-reactivity), 17β-estradiol (0.01% cross-reactivity) and cortisol (0.01% cross-reactivity) ensured the accuracy of dRIA procedure. Almost all testosterone antisera show some degree of cross-reactivity with DHT, but show negligible cross-reactivity with other androgens. In most clinical situations, estimation of testosterone without prior separation of DHT is permitted because plasma concentrations of DHT are only 10-20% of those for testosterone. Moreover, as testosterone and DHT are the two most important androgens in the systemic circulation, even when a method measures the concentrations of both of them, clinically useful information about the total androgen load is still obtained. Thus, in general, extraction and purification before RIA procedure are not recommended in dRIA.
Keelan et al. cited only three papers from the same team in their review to support the misleading conclusion that appropriate extraction procedures must be applied to cord blood samples to avoid cross-reactivity (Troisi et al., 2003a (Troisi et al., ,b, 2008 . Noticeably, cord sex hormones were all detected by a conventional RIA in these papers. If the extraction procedure is a general practice in measuring cord testosterone, more papers should have been cited to support their argument. Reply II. Cord blood androgen measurements: the importance of assay validation
Sir,
We thank Keelan and colleagues for their letter questioning the accuracy of testosterone measurement in cord blood obtained by immunoassay methods.
In our study of the association between in utero exposure to persistent organic pollutants and hormone levels in cord blood (Warembourg et al., 2016) , we relied on immunoassay methods for the determination of testosterone in cord blood. In the Discussion of our paper, we expressed reservations about our results related to testosterone measurements. At the time we measured these hormone levels in our cohort (in 2009), we were not aware of the low accuracy of immunoassay methods for measuring steroids in cord blood. Since the publication of the recent review by , which stressed that immunoassay methods are not the ideal method to measure cord blood steroids due to cross reaction, we have moved toward the use of liquid chromatography-mass spectrometry assays for steroid determination. In a subset of newborns (n = 23), testosterone and estradiol levels were measured by both analytical methods: despite considerably higher levels of testosterone measured by immunoassay methods (median level: 2116 ng/l vs 90 ng/l), we observed a significant correlation between testosterone levels (ρ = 0.53, P-value = 0.01). This correlation was much higher for estradiol (ρ = 0.88, P-value < 0.0001). This finding demonstrates that measurement by immunoassay can reasonably be used in association studies that compare subjects with high testosterone levels to subjects with lower levels measured by the same method. In addition, as expected, we observed higher testosterone levels among male than female newborns. This, in addition to the correlation we observed, has reinforced our confidence about the conclusions of association tests using immunoassays. The measurement error encountered by the use of immunoassay is likely to be nondifferential, and this kind of error generally leads to an underestimation of the associations. Therefore, we can reasonably consider that the associations we reported for testosterone are not as unfounded as Keelan and colleagues suggest, but may have been underestimated.
